Skip to main content
    C

    CervoMed Inc. (CRVO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.50
    -0.17 (-10.18%)

    Market Cap: $25.26M

    Last updated: Nov 17, 2026 at 4:42 PM ET

    CervoMed Inc. (CRVO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    CervoMed (CRVO) has a market cap of $25.26M and an enterprise value of $19.20M. It kept -326822.54% of revenue as net income over the last 12 months. Its share count is up 63.40% from a year earlier.

    Total Valuation

    Enterprise value is 23.99% below the market cap, as cash exceeds debt.

    Market Cap$25.26M
    Enterprise Value$19.20M
    Latest price (Nov 17, 2026)$1.50

    Key Dates

    The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 11, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 47.58% in the quarter ended Sep 30, 2026 and grew 31.81% a year over 2 years.

    Shares Outstanding15.12M
    Shares Change (YoY)+63.40%
    Shares Change (QoQ)+47.58%
    Share Count Growth (2Y CAGR)+31.81%

    Price Statistics

    The stock is down 80.47% over 52 weeks and trades 34.78% below its 50-day average.

    Beta (1Y)2.20
    52-Week Change-80.47%
    1-Month Change-35.06%
    3-Month Change-44.65%
    6-Month Change-48.10%
    5-Year Change-95.30%
    10-Year Change-99.96%
    Total Return (1Y)-80.47%
    Total Return (3Y CAGR)-46.63%
    Total Return (5Y CAGR)-45.13%
    Return vs SPY (1Y)-93.49%
    Max Drawdown (1Y)-86.22%
    Max Drawdown (3Y)-94.72%
    Sharpe Ratio (1Y)-1.58
    Correlation with SPY (1Y)0.28
    50-Day Average$2.30
    200-Day Average$3.24
    52-Week Range$1.27 to $10.00
    RSI (14 Days)35.3
    Average Volume (20 Days)983.26K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.37x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio5.37x
    Quick Ratio5.37x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -164.32% and return on assets is -133.70% over the last 12 months.

    Return on Equity (ROE)-164.32%
    Return on Assets (ROA)-133.70%
    ROA (5Y Average)-76.14%
    Asset Turnover0.00x

    Scores

    CRVO has an Altman Z-Score of -7.87, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-7.87
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $8.73K over the last 12 months is down 99.86% from the 12 months before.

    Revenue$8.73K
    Revenue Growth (YoY)-99.86%
    Gross Profit$8.73K
    Operating Income-$29.23M
    Pretax Income-$28.52M
    Net Income-$28.52M
    Reported EPS (TTM)-$2.77

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 81.39% of the $21.33M in total assets.

    Cash and Equivalents$6.06M
    Total Debt$0
    Net Cash$6.06M
    Net Cash Per Share$0.40
    Working Capital$17.36M
    Shareholder Equity$17.36M
    Book Value Per Share$1.15
    Total Assets$21.33M
    Total Liabilities$3.97M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$26.59M
    FCF Per Share-$1.76
    Depreciation and Amortization$345.48K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -334924.87%.

    Gross Margin100.00%
    Operating Margin-334924.87%
    Pretax Margin-326822.54%
    Net Margin-326822.54%

    Growth

    Book Value Per Share Growth (2Y CAGR)+23.09%
    Tangible Book Per Share Growth (2Y CAGR)+23.09%

    Revenue and profit by year

    Dividends and Yields

    CRVO does not pay a dividend.

    Buyback Yield1.59%
    Shareholder Yield1.59%

    Stock Splits

    The last reverse split was on Aug 17, 2023.

    Last Split DateAug 17, 2023
    Split TypeReverse split

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CRVO

    What is CRVO's market cap?

    CervoMed has a market cap of $25.26M. Its enterprise value, which adds debt and subtracts cash, is $19.20M.

    How many shares of CRVO are outstanding?

    CervoMed has 15.12M shares outstanding. The count is up 63.40% from a year earlier.

    Does CRVO pay a dividend?

    No. CervoMed does not pay a dividend.

    How much debt does CRVO have?

    CervoMed has $0 of total debt and $6.06M of cash and equivalents, a net cash position of $6.06M.